Skip to main content

Egyptian Biotech Group Seeks 'Omics Partners

NEW YORK (GenomeWeb News) – The Egyptian Organization for Biotechnology and Vaccines is seeking partners to work with it on a variety of research program areas focused largely on genotyping and pharmacogenetics in cancer and in autoimmune diseases, the European Commission said this week.

The Cairo-based lab seeks partners for collaborative projects of small, medium, and large scales that could involve a range of research areas.

These projects could involve research into pharmacogenomics and pharmacogenetics research; bioinformatics; epigenetic applications in gene therapy for autoimmune diseases; epigenetic applications in gene therapy for autoimmune disease; human molecular diseases that could include DNA-based technologies; developing real-time PCR for quantifying gene expression related to diabetes, cancer, and leukemia; and proteomics and metabolomics applications of disease treatment, among others.

More information about the partnership request is available at the European Commission’s Seventh Framework Program website.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.